XML 47 R36.htm IDEA: XBRL DOCUMENT
v3.25.1

Financial Assets and Liabilities (Tables) | 6 Months Ended
--- | ---
Apr. 30, 2025
Financial Assets And Liabilities [Abstract] |
Schedule of Cash Equivalents and Short-Term Investments | As of April 30, 2025, the balances of our cash equivalents and short-term investments are as follows:
| Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses Less Than 12 Continuous Months |  | Gross Unrealized Losses 12 Continuous Months or Longer |  | Estimated Fair Value(1)
| (in thousands)
Cash equivalents: |  |  |  |  |  |  |  |  |
Money market funds | $ | 630,455 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 630,455 |
Total: | $ | 630,455 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 630,455 |
Short-term investments: |  |  |  |  |  |  |  |  |
U.S. Treasury, agency & T-bills | $ | 15,009 |  |  | $ | 30 |  |  | $ | — |  |  | $ | — |  |  | $ | 15,039 |
Corporate debt securities | 102,630 |  |  | 320 |  |  | (45) |  |  | — |  |  | 102,905 |
Asset-backed securities | 26,794 |  |  | 95 |  |  | (5) |  |  | (12) |  |  | 26,872 |
Total: | $ | 144,433 |  |  | $ | 445 |  |  | $ | (50) |  |  | $ | (12) |  |  | $ | 144,816 |
(1)See Note 9. Fair Value Measurements for further discussion on fair values. The contractual maturities of our available-for-sale debt securities as of April 30, 2025 are as follows:
| Amortized Cost |  | Fair Value
| (in thousands)
1 year or less | $ | 75,105 |  |  | $ | 75,243 |
1-5 years | 65,249 |  |  | 65,488 |
5-10 years | 1,689 |  |  | 1,699 |
>10 years | 2,390 |  |  | 2,386 |
Total | $ | 144,433 |  |  | $ | 144,816 |
As of October 31, 2024, the balances of our cash equivalents and short-term investments are as follows:
| Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses Less Than 12 Continuous Months |  | Gross Unrealized Losses 12 Continuous Months or Longer |  | Estimated Fair Value(1)
| (in thousands)
Cash equivalents: |  |  |  |  |  |  |  |  |
Money market funds | $ | 869,972 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 869,972 |
U.S. Treasury, agency & T-bills | 7,984 |  |  | 1 |  |  | — |  |  | — |  |  | 7,985 |
Total: | $ | 877,956 |  |  | $ | 1 |  |  | $ | — |  |  | $ | — |  |  | $ | 877,957 |
Short-term investments: |  |  |  |  |  |  |  |  |
U.S. Treasury, agency & T-bills | $ | 19,411 |  |  | $ | 44 |  |  | $ | (6) |  |  | $ | — |  |  | $ | 19,449 |
Corporate debt securities | 105,024 |  |  | 349 |  |  | (115) |  |  | (2) |  |  | 105,256 |
Asset-backed securities | 29,061 |  |  | 130 |  |  | (7) |  |  | (20) |  |  | 29,164 |
Total: | $ | 153,496 |  |  | $ | 523 |  |  | $ | (128) |  |  | $ | (22) |  |  | $ | 153,869 |
(1)See Note 9. Fair Value Measurements for further discussion on fair values.
Schedule of Cash, Cash Equivalents and Restricted Cash | The following table provides a reconciliation of cash, cash equivalents and restricted cash included in the condensed consolidated balance sheets and the condensed consolidated statements of cash flows:
| As of
| April 30, 2025 |  | October 31, 2024
| (in thousands)
Cash and cash equivalents | $ | 14,119,095 |  |  | $ | 3,896,532 |
Restricted cash included in prepaid and other current assets | 3,288 |  |  | 1,529 |
Restricted cash included in other long-term assets | 1,050 |  |  | 668 |
Cash, cash equivalents and restricted cash | $ | 14,123,433 |  |  | $ | 3,898,729 |
Schedule of Effects on Changes in Fair Values of Non-Designated Forward Contracts | The effects of the non-designated foreign currency derivative instruments in the condensed consolidated statements of income are summarized as follows:
| Three Months Ended April 30, |  | Six Months Ended April 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
| (in thousands)
Gains (losses) recorded in other income (expense), net | $ | 11,186 |  |  | $ | (4,355) |  |  | $ | 6,765 |  |  | $ | (1,066) |
Schedule of Notional Amounts of Foreign Currency Derivative Instruments | The notional amounts in the table below for foreign currency derivative instruments provide one measure of the transaction volume outstanding:
| As of
| April 30, 2025 |  | October 31, 2024
| (in thousands)
Total gross notional amounts | $ | 1,243,451 |  |  | $ | 1,686,341 |
Net fair value | $ | 2,959 |  |  | $ | 1,819 |
Schedule of Fair Values of Foreign Currency Derivative Instrument Designated and Non-Designated as Hedging Instruments in Balance Sheet | The following table represents the condensed consolidated balance sheets location and amount of foreign currency derivative instrument fair values segregated between designated and non-designated hedge instruments:
| Fair values of derivative instruments designated as hedging instruments |  | Fair values of derivative instruments not designated as hedging instruments
| (in thousands)
Balance at April 30, 2025 |  |  |
Other current assets | $ | 9,135 |  |  | $ | 5 |
Accrued liabilities | $ | 6,037 |  |  | $ | 144 |
Balance at October 31, 2024 |  |  |
Other current assets | $ | 8,839 |  |  | $ | 12 |
Accrued liabilities | $ | 6,918 |  |  | $ | 114 |
Schedule of Location of the Amounts of Gains and Losses on Derivative Instrument Fair Values for Designated Hedging Instruments, Net of Tax | The following table represents the location of the amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax in the condensed consolidated statements of income:
| Location of gains (losses) recognized in OCI on derivatives |  | Amount of gains (losses) recognized in OCI on derivatives (effective portion) |  | Location of gains (losses) reclassified from OCI |  | Amount of gains (losses) reclassified from OCI (effective portion)
| (in thousands)
Three months ended April 30, 2025 |  |  |  |  |  |  |
Foreign exchange contracts | Revenue |  | $ | 12,689 |  |  | Revenue |  | $ | 1,282 |
Foreign exchange contracts | Operating expenses |  | 14,749 |  |  | Operating expenses |  | (3,069) |
Interest rate contracts | Interest expenses |  | (73,146) |  |  | Interest expenses |  | (888) |
Total |  |  | $ | (45,708) |  |  |  |  | $ | (2,675) |
Three months ended April 30, 2024 |  |  |  |  |  |  |
Foreign exchange contracts | Revenue |  | $ | (2,507) |  |  | Revenue |  | $ | (1,019) |
Foreign exchange contracts | Operating expenses |  | (4,628) |  |  | Operating expenses |  | (137) |
Total |  |  | $ | (7,135) |  |  |  |  | $ | (1,156) |
Six months ended April 30, 2025 |  |  |  |  |  |  |
Foreign exchange contracts | Revenue |  | $ | 13,203 |  |  | Revenue |  | $ | 280 |
Foreign exchange contracts | Operating expenses |  | (2,142) |  |  | Operating expenses |  | (5,655) |
Interest rate contracts | Interest expenses |  | (93,216) |  |  | Interest expenses |  | (888) |
Total |  |  | $ | (82,155) |  |  |  |  | $ | (6,263) |
Six months ended April 30, 2024 |  |  |  |  |  |  |
Foreign exchange contracts | Revenue |  | $ | (2,565) |  |  | Revenue |  | $ | (4,282) |
Foreign exchange contracts | Operating expenses |  | 6,040 |  |  | Operating expenses |  | (152) |
Total |  |  | $ | 3,475 |  |  |  |  | $ | (4,434) |

X
- Definition Financial Assets and Liabilities [Abstract] + References No definition available. + Details
Name: | snps_FinancialAssetsAndLiabilitiesAbstract
Namespace Prefix: | snps_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash and cash equivalents. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4CC -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 182 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480401/815-10-55-182 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item. + References No definition available. + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4CC -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 8 -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8 + Details
Name: | us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration